Safety Information

Introduction
5
Limitations
Substance Concentration
The interference listed below have been tested and shown no apparent
influence on results at the normal or higher therapy levels.
Other interfering substances in ISO 15197 Annex A are not verified, it may
also affect the test results.
Acetaminophen 1.11 mmol/L (20 mg/dL)
Bilirubin 2.22 mmol/L (40 mg/dL)
Creatinine 0.56 mmol/L (10 mg/dL)
Gentisic acid 55.56 mmol/L (1000 mg/dL)
Hemoglobin 27.78 mol/L (500 mg/dL)
Ibuprofen 2.78 mmol/L (50 mg/dL)
L-Dopa 0.03 mmol/L (0.5 mg/dL)
Methyldopa 55.56 mmol/L (1000 mg/dL)
Tolbutamide 5.55 mmol/L (100 mg/dL)
Triglycerides 83.33 mmol/L (1500 mg/dL)
Xylose 11.11 mmol/L (200 mg/dL)
EDTA 11.11 mmol/L (200 mg/dL)
Substance Concentration
Ascorbic acid 0.17 mmol/L (3 mg/dL)
Cholesterol 27.78 mmol/L (500 mg/dL)
Dopamine 0.11 mmol/L (2 mg/dL)
Glutathione 5.11 mmol/L (92 mg/dL)
Heparin 500 IU/dL
Icodextrin 60.8 mmol/L (1094.4 mg/dL)
Maltose 555.56 mmol/L (10,000 mg/dL)
Salicylic acid 3.33 mmol/L (60 mg/dL)
Tolazamide 2.22 mmol/L (40 mg/dL)